HYTN Innovations Inc.HYTN.CN

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · CSE · Canada · hytn.ca

HYTN Innovations Inc. is a pharmaceutical company specializing in the formulation, manufacturing, marketing and sale of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids. It serves federally regulated markets worldwide by applying pharmaceutical-grade development, manufacturing and quality systems.

Key ratios

FCF / Sales

-15.5%TTM

2025 -35.3%2024 -93.4%2023 -154.7%

Net margin

-46.9%TTM

2025 -90.6%

ROA

-31.7%TTM

2025 -26.8%2024 -65.7%2023 -32.3%

ROE

-37727.9%TTM

2024 -9333.2%2023 -195.5%

Revenue growth

194.3%TTM

2025 96.6%2024 11.5%2023 9.6%

Recent news

HYTN Announces Arrangement Agreement to Facilitate the Spin-Out of a Peptide-Focused Drug Development Business 2026-09-02 · GlobeNewswire

Track HYTN.CN in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer